Bluejay Diagnostics Files 8-K on Security Holder Vote

Ticker: BJDX · Form: 8-K · Filed: 2024-08-21T00:00:00.000Z

Sentiment: neutral

Topics: shareholder-vote, corporate-governance

TL;DR

Bluejay Diagnostics is having a shareholder vote soon, details to follow.

AI Summary

On August 21, 2024, Bluejay Diagnostics, Inc. filed an 8-K report to announce the submission of matters to a vote of its security holders. The filing does not contain specific details about the matters to be voted on or any associated financial implications at this time.

Why It Matters

This filing indicates that Bluejay Diagnostics is convening a meeting where shareholders will vote on important company matters, which could impact the company's future direction.

Risk Assessment

Risk Level: low — The filing is procedural and does not disclose any immediate financial risks or significant operational changes.

Key Players & Entities

FAQ

What specific matters will be submitted for a vote by Bluejay Diagnostics' security holders?

The filing does not specify the exact matters to be voted on, only that matters are being submitted for a vote.

When is the anticipated date for the security holders' vote?

The filing does not provide a specific date for the vote, only that the report is being filed on August 21, 2024.

Has Bluejay Diagnostics provided any details regarding the implications of these upcoming votes?

No, the filing does not include any information about the potential implications of the matters to be voted on.

What is the principal executive office address for Bluejay Diagnostics?

The principal executive offices are located at 360 Massachusetts Avenue, Suite 203, Acton, MA 01720.

What is the company's telephone number?

The company's telephone number is (844) 327-7078.

Filing Stats: 836 words · 3 min read · ~3 pages · Grade level 12.3 · Accepted 2024-08-21 14:17:35

Key Financial Figures

Filing Documents

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. On August 21, 2024, the Company held a Special Meeting of Stockholders (the "Special Meeting"). As of June 24, 2024, the record date for the Special Meeting, there were 563,960 shares of the Company's common stock issued and outstanding and entitled to vote on the proposals presented at the Special Meeting, of which 300,978, or 53.4%, were present in person or represented by proxy, which constituted a quorum. Shareholders were entitled to one vote for each share of common stock held. There were 141,991 broker non-voted shares with respect to Proposals 2 and 3. Proposal 4, the proposal to approve one or more adjournments to the meeting, if necessary or appropriate, was not voted or acted on at the Special Meeting. Set forth below are the final voting results for each of the proposals submitted to a vote of the Company's stockholders at the Special Meeting: Proposal 1. Approval and adoption of an amendment to the Company's amended and restated certificate of incorporation, as amended, to increase the number of authorized shares of the Company's common stock - The Company's stockholders approved and adopted an amendment to the Company's amended and restated certificate of incorporation, as amended, to increase the number of authorized shares of the Company's common stock. The Company intends to promptly file the approved and adopted amendment to the certificate of incorporation with the Secretary of State of the State of Delaware. The voting results for the proposal were as follows: Votes For Votes Against Abstain 223,019 32,958 45,001 Proposal 2. Approval, pursuant to Nasdaq Listing Rule 5635(d), of the issuance of the Class C warrants to purchase shares of the Company's common stock in connection with an offering and sale of securities of the Company that was consummated on June 28, 2024 - The Company's stockholders approved, pursuant to Nasdaq Listing Rule 5635(d), the issuance of the C

View on Read The Filing